Curr Treat Options Cardiovasc Med. 2003 Aug;5(4):259-269. doi: 10.1007/s11936-003-0025-9.

Diet, Weight Loss, and Cardiovascular Disease Prevention.

Current treatment options in cardiovascular medicine

George A. Bray, Donna H. Ryan, David W. Harsha

PMID: 12834563 DOI: 10.1007/s11936-003-0025-9

Abstract

Body weight, like cholesterol and blood pressure, are continuous variables. Overweight results when energy intake as food exceeds energy expenditure from exercise for a considerable period of time. When body weight becomes sufficiently high, it poses a risk to cardiovascular and metabolic health. The types of treatments considered by the physician and discussed with a patient should be based on this risk-benefit assessment. The body mass is the basic measurement for this assessment, and should be part of the "vital signs" when a patient is first evaluated by the medical staff. When the body mass index (BMI) is below 25 kg/m(2), there is little risk from the body weight, but because obesity is a "stigmatized" condition, many patients, particularly women, desire to lose weight even within the normal range. For this purpose, a high-quality diet like the Dietary Approaches to Stopping Hypertension (DASH) diet at a reduced-calorie intake would be our recommendation. When the BMI is above 25 kg/m(2), patients deserve dietary advice, but in addition to a reduced-calorie DASH-like diet, this is a place to consider using "portion-control" strategies, such as the nutrition labels that manufacturers provide on canned and frozen foods to guide patients in reducing calorie intake. In overweight individuals at high risk (ie, those with a BMI above 30 kg/m(2) or impaired glucose tolerance, hypertension, or the metabolic syndrome), the use of orlistat or sibutramine along with diet, exercise, lifestyle changes, and portion control should be considered. When the BMI is above 35 kg/m(2), bariatric surgery should also be discussed as an option for the "at-risk" individual. Evidence reviewed here shows that modest weight losses of 5% to 10% can reduce the risk of conversion from impaired glucose tolerance to diabetes and can maintain lower blood pressure over extended periods. All of the approaches described above can produce weight losses of this magnitude.

References

1. Lancet. 2000 Dec 23-30;356(9248):2119-25 - PubMed
2. JAMA. 1999 Jan 20;281(3):235-42 - PubMed
3. Endocr Rev. 1999 Dec;20(6):805-75 - PubMed
4. Obes Res. 2000 Sep;8(6):431-7 - PubMed
5. Arch Intern Med. 2001 Jan 22;161(2):218-27 - PubMed
6. Eur J Clin Nutr. 1999 May;53(5):379-81 - PubMed
7. Arch Fam Med. 2000 Feb;9(2):160-7 - PubMed
8. Diabetes Care. 1998 Aug;21(8):1288-94 - PubMed
9. Obes Res. 1999 Mar;7(2):189-98 - PubMed
10. Arch Intern Med. 2000 May 8;160(9):1321-6 - PubMed
11. J Clin Endocrinol Metab. 2001 Sep;86(9):4382-9 - PubMed
12. Diabetes Obes Metab. 2000 Jun;2(3):175-87 - PubMed
13. Int J Obes Relat Metab Disord. 2001 Mar;25(3):316-24 - PubMed
14. JAMA. 1998 Nov 11;280(18):1596-600 - PubMed
15. Hypertension. 2000 Jul;36(1):20-5 - PubMed
16. J Hum Hypertens. 2002 Jan;16(1):5-11 - PubMed
17. Obes Res. 2000 Jan;8(1):49-61 - PubMed
18. JAMA. 1994 Jul 20;272(3):205-11 - PubMed
19. Lancet. 1998 Jul 18;352(9123):167-72 - PubMed
20. Ann Intern Med. 2001 Jan 2;134(1):1-11 - PubMed
21. Obes Res. 1999 Sep;7(5):477-84 - PubMed
22. Int J Obes Relat Metab Disord. 2002 May;26(5):593-604 - PubMed
23. Arch Intern Med. 2000 Jul 24;160(14):2185-91 - PubMed
24. Obes Res. 2001 Oct;9(10):599-604 - PubMed
25. JAMA. 2002 Oct 9;288(14):1723-7 - PubMed
26. JAMA. 2001 Sep 19;286(11):1331-9 - PubMed
27. Am J Cardiol. 2001 Apr 1;87(7):827-31 - PubMed

Publication Types

• Journal Article